ReviewCureus2024
Applications of Artificial Intelligence in Ophthalmology: Glaucoma, Cornea, and Oculoplastics.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Artificial intelligence in the diagnosis and prognosis of ocular trauma: a systematic review.BMC ophthalmology · 2026Pooled it
- Interventional Keratoconus Management: The Critical Imperative for Early Detection and Treatment.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Identifying diagnostic biomarkers for glaucoma based on transcriptome combined with Mendelian randomization.Scientific reports · 2025Article
- Artificial Intelligence in Oculoplastics: A Survey-Based Study on Provider Perspective.Cureus · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Artificial intelligence (AI) is transforming ophthalmology by leveraging machine learning (ML) and deep learning (DL) techniques, particularly artificial neural networks (ANN) and convolutional neural networks (CNN) to mimic human brain functions and enhance accuracy through data exposure. These AI systems are particularly effective in analyzing ophthalmic images for early disease detection, improving diagnostic precision, streamlining clinical workflows, and ultimately enhancing patient outcomes. This study aims to explore the specific applications and impact of AI in the fields of glaucoma, corneal diseases, and oculoplastics. This study reviews current AI technologies in ophthalmology, examining the implementation of ML and DL techniques. It evaluates AI's role in early disease detection, diagnostic accuracy, clinical workflow enhancement, and patient outcomes. AI has significantly advanced the early detection and management of various ocular conditions. In glaucoma, AI systems provide standardized, rapid identification of disease characteristics, reducing intra- and interobserver bias and workload. For corneal diseases, AI tools enhance diagnostic methods for conditions such as keratitis and keratoconus, improving early detection and treatment planning. In oculoplastics, AI assists in the diagnosis and monitoring of eyelid and orbital diseases, facilitating precise surgical planning and postoperative management. The integration of AI in ophthalmology has revolutionized eye care by enhancing diagnostic precision, streamlining clinical workflows, and improving patient outcomes. As AI technologies continue to evolve, their applications in ophthalmology are expected to expand, offering innovative solutions for the diagnosis, monitoring, treatment, and surgical outcomes of various eye conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.